Di Zhang

Di Zhang is a highly experienced scientist with a robust background in pharmaceutical development and nanotechnology. Currently serving as a Project Responsible and Senior Scientist at Sever Pharma Solutions since March 2019, Di Zhang has previously held senior roles at AstraZeneca, contributing to the advancement of drug particle modification for inhalation applications. Academic contributions include significant research at the Suzhou Institute of Nano-Tech and Nano-Bionics and Åbo Akademi University, where Di Zhang focused on coordinating international research collaborations. With a Ph.D. in Biomaterials from Åbo Akademi University and extensive experience in scientific consulting, Di Zhang has demonstrated expertise in research project implementation, communication with industry partners, and publication in international scientific forums.